OTCMKTS:CLPBY Coloplast A/S (CLPBY) Stock Price, News & Analysis $6.60 0.00 (0.00%) As of 10/9/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsInsider TradesNews and TrendsShort Interest About Coloplast A/S Stock (OTCMKTS:CLPBY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Coloplast A/S alerts:Sign Up Key Stats Today's Range$6.53▼$6.6350-Day Range$6.18▼$7.4052-Week Range$5.64▼$9.70Volume168,261 shsAverage Volume264,435 shsMarket Capitalization$14.87 billionP/E Ratio34.74Dividend Yield1.21%Price TargetN/AConsensus RatingHold Company Overview Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology. The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management. Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy. The company was established in 1957 by Aage Louis-Hansen and his wife, Johanne Louis-Hansen. Headquartered in Humlebæk, Denmark, Coloplast serves healthcare professionals and patients in markets across Europe, North America, and other international regions. Kristian Villumsen has served as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Receive CLPBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLPBY Stock News HeadlinesHead to Head Analysis: Elutia (NASDAQ:ELUT) and Coloplast A/S (OTCMKTS:CLPBY)October 5, 2026 | americanbankingnews.comCLPBY Share News TodayJune 22, 2026 | uk.investing.comI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called to our community before the big move happened… And right now, I'm making my next big call. It's a coin trading under $1.00… one most investors have never even heard of. But the world's largest bank is already building on it. It has a burn mechanism wired directly to institutional usage… meaning the more the big money uses it, the more rare it becomes. And its biggest supply cut in history happened earlier this year…October 12 at 1:00 AM | Crypto 101 Media (Ad)Coloplast's Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of menJune 3, 2026 | globenewswire.comColoplast: Went 'BUY' A Bit EarlyMay 16, 2026 | seekingalpha.comColoplast: The Market Is Throwing Away A High-Quality CompounderMarch 17, 2026 | seekingalpha.comColoplast appoints Gavin Wood as new CEOMarch 4, 2026 | globenewswire.comColoplast A/S - Updated Financial Calendar 2025-26February 11, 2026 | globenewswire.comSee More Headlines CLPBY Stock Analysis - Frequently Asked Questions How have CLPBY shares performed this year? Coloplast A/S's stock was trading at $8.50 at the start of the year. Since then, CLPBY stock has decreased by 22.4% and is now trading at $6.60. How were Coloplast A/S's earnings last quarter? Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) posted its quarterly earnings results on Tuesday, August, 18th. The company reported $0.10 earnings per share for the quarter, meeting analysts' consensus estimates of $0.10. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a trailing twelve-month return on equity of 39.27% and a net margin of 9.68%. How do I buy shares of Coloplast A/S? Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/18/2026Today10/12/2026Next Earnings (Estimated)11/03/2026Fiscal Year End9/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:CLPBY Previous SymbolNASDAQ:CLPBY CIK1294325 Webwww.coloplast.com Phone(454) 911-1111FaxN/AEmployees17,156Year Founded1957Profitability EPS (Trailing Twelve Months)$0.19 Trailing P/E Ratio34.74 Forward P/E Ratio16.50 P/E Growth2.35Net Income$538.49 million Net Margins9.68% Pretax Margin13.97% Return on Equity39.27% Return on Assets11.54% Debt Debt-to-Equity Ratio1.51 Current Ratio1.56 Quick Ratio0.94 Sales & Book Value Annual Sales$4.13 billion Price / Sales3.60 Cash Flow$0.36 per share Price / Cash Flow18.41 Book Value$1.06 per share Price / Book6.23Miscellaneous Outstanding Shares2,253,670,000Free FloatN/AMarket Cap$14.87 billion OptionableNot Optionable Beta0.21 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:CLPBY) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave,...Tim Sykes | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPBY Stock Alerts